• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . A multi-country qualitative evaluation of rapid mortality surveillance during the COVID-19 pandemic

tetano

Editor, Senior Moderator
PLoS One


. 2026 Jul 6;21(7):e0333157.
doi: 10.1371/journal.pone.0333157. eCollection 2026.
A multi-country qualitative evaluation of rapid mortality surveillance during the COVID-19 pandemic

Carlie Congdon[SUP] 1 [/SUP], Farnaz Malik[SUP] 2 [/SUP], Ruxana Jina[SUP] 2 [/SUP], Diana Kumar[SUP] 1 [/SUP], Philip W Setel[SUP] 1 [/SUP]


Affiliations
Abstract

Background: Low- and middle-income countries without well-functioning civil registration and vital statistics (CRVS) systems struggle to obtain accurate and complete counts of total (i.e., all-cause) mortality, especially during a pandemic. The aim of this evaluation was to assess whether rapid mortality surveillance (RMS) provided timely and useful counts of deaths to inform pandemic response, despite competing demands on government and public health responders, during the COVID-19 pandemic. This is the first published evaluation of efforts to test the feasibility, utility, and impact of efforts to improve or establish mortality surveillance.
Methods: We supported 13 low- and middle-income countries to implement RMS during the first wave of the COVID-19 pandemic. From August to October 2021, we conducted a qualitative assessment of each country's progress.
Results: Analysis of in-depth interviews with 16 respondents in 13 countries surfaced common themes related to facilitators of RMS implementation. These include 1) government ownership and buy-in; 2) data collection and digitalization; 3) interagency collaboration and data sharing; 4) data analysis and interpretation; and 5) data use for decision-making.
Conclusion: Robust and digitalized CRVS systems can serve the rapid mortality surveillance function well. For locations where digitalization and connectivity of systems are still improving, more feasible and fit-for-purpose approaches are needed. These findings should inform the development of CRVS mortality surveillance functions in low- and middle-income countries.


 
Back
Top